Cyclophosphamide/docetaxel/trastuzumabNeutropenia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1824卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84072-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：104 / 104

相关论文

共 50 条

[21] Cyclophosphamide/docetaxel/doxorubicinBenign melanonychia striata: case report
Reactions Weekly, 2014, 1492 (1) : 18 - 18
[22] Cyclophosphamide/docetaxel/doxorubicinPneumatosis cystoides intestinalis: case report
Reactions Weekly, 2020, 1791 (1) : 83 - 83
[23] Cyclophosphamide/docetaxel/epirubicinHepatitis C reactivation: case report
Reactions Weekly, 2017, 1671 (1) : 141 - 141
[24] Cyclophosphamide/docetaxel/epirubicinTumour flare reaction: case report
Reactions Weekly, 2010, 1284 (1) : 19 - 19
[25] Cyclophosphamide/docetaxel/epirubicinBone marrow suppression: case report
Reactions Weekly, 2016, 1619 (1) : 76 - 76
[26] Cyclophosphamide/docetaxel/doxorubicinStomatitis and low back pain: case report
Reactions Weekly, 2019, 1773 (1) : 120 - 120
[27] Cyclophosphamide/docetaxel/doxorubicinFlare-up of dermatomyositis: case report
Reactions Weekly, 2022, 1894 (1) : 122 - 122
[28] Cyclophosphamide/docetaxel/pembrolizumabScleroderma-like lesions: case report
Reactions Weekly, 2024, 2022 (1) : 100 - 100
[29] Cyclophosphamide/docetaxel/pirarubicinNeutropenia and multiple organ dysfunction syndrome: case report
Reactions Weekly, 2016, 1588 (1) : 93 - 93
[30] Cyclophosphamide/docetaxel/letrozoleLongitudinal melanonychia and Muehrcke's lines: case report
Reactions Weekly, 2019, 1735 (1) : 97 - 97

← 1 2 3 4 5 →